retatrutide blindness and Thyroid Cancer: Why the Warning Exists Retatrutide Delivers Bariatric-Level Weight Loss

Even the most affordable option, Byetta, becomes costlier than surgery after around 1.5 years

Gentle Patches GLP-1 markets itself as containing herbal GLP-1 mimetics like berberine and gymnema, positioning itself as a natural alternative

The phase 2 signal that put retatrutide on the map The pivotal early evidence is the phase 2 trial published in the New England Journal of Medicine in 2023, which randomized 338 adults with obesity to escalating retatrutide doses or placebo over 48 weeks

The qualifying comorbidities deserve attention because many people have them without realizing it

Enhanced GIP secretion in obesity is associated with biochemical alteration and miRNA contribution to the development of liver steatosis